Zheng, X., Cui, B., Hou, W., Zhao, Z., He, S., Li, X., . . . Zhang, L. (2025). The additive value of fractionated 177Lu-PSMA-617 administration in treating prostate cancer. Journal of Radioanalytical & Nuclear Chemistry, 334(1), 99. https://doi.org/10.1007/s10967-024-09845-4
Chicago Style (17th ed.) CitationZheng, Xiaobei, et al. "The Additive Value of Fractionated 177Lu-PSMA-617 Administration in Treating Prostate Cancer." Journal of Radioanalytical & Nuclear Chemistry 334, no. 1 (2025): 99. https://doi.org/10.1007/s10967-024-09845-4.
MLA (9th ed.) CitationZheng, Xiaobei, et al. "The Additive Value of Fractionated 177Lu-PSMA-617 Administration in Treating Prostate Cancer." Journal of Radioanalytical & Nuclear Chemistry, vol. 334, no. 1, 2025, p. 99, https://doi.org/10.1007/s10967-024-09845-4.